ROSG Rosetta Genomics Ltd. featured news, full reports, and detailed charts
Rosetta Genomics Ltd. (ROSG) Wrap Up:
We were incorporated in Israel on March 9, 2000. Our principal executive office is located at 10 Plaut Street, Science Park, Rehovot 76706 Israel, and our telephone number is + 972-8-948-4755. Our wholly owned subsidiary, Rosetta Genomics Inc., which was incorporated in Delaware on April 21, 2005, is located at 675 U.S. Highway One, Suite B119, North Brunswick, New Jersey 08902, and its telephone number is (732) 246-9900. Rosetta Genomics Inc. serves as our agent for service of process in the United States. Our internet address is www.rosettagenomics.com. The information on our web site is not incorporated by reference into this Annual Report and should not be considered to be a part of this Annual Report. We completed the initial public offering of our ordinary shares in the United States on March 2, 2007. In connection with the initial public offering, on October 4, 2006, we (i) effected a 1-for-3. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2007%2f05%2f21%2f0001144204-07-027598.html#FIS_COMPANY_INFORMATION"Rosetta Genomics, Ltd. (ROSG:NASDAQ)
Snapshot of Rosetta Genomics, Ltd. (ROSG)
|
OPEN
$2.21
|
PREVIOUS CLOSE
$2.25
|
|
|
DAY HIGH
$2.25
|
DAY LOW
$2.12
|
|
|
52 WEEK HIGH
04/14/09 - $3.80
|
52 WEEK LOW
12/26/08 - $1.08
|
|
|
MARKET CAP
31.3M
|
AVERAGE VOLUME 3 mo
14.2K
|
|
|
DILUTED EPS TTM
$-0.68
|
SHARES OUTSTANDING
14.2M
|
|
|
ROSG Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
ROSG Top Compensated Officers
Executives, Board Directors
Key developments for Rosetta Genomics, Ltd. (ROSG)
Rosetta Genomics Ltd. announced the appointment of Kenneth A. Berlin to the position of president and chief executive officer, effective November 2, 2009. Rosetta Genomics' board of directors has recommended that Mr. Berlin also be appointed to serve on the Rosetta Genomics' board of directors. Prior to his appointment as president and CEO of Rosetta Genomics, since July 2007, Mr. Berlin served as worldwide General Manager at cellular and molecular cancer diagnostics developer Veridex, LLC, a Johnson & Johnson company.
Rosetta Genomics, Ltd. expected to Report Fiscal Year 2009 Results on March 19, 2010. This event was calculated by Capital IQ (Created on November 2, 2009).
Rosetta Genomics, Ltd. expected to Report Q3 2009 Results on November 25, 2009. This event was calculated by Capital IQ (Created on November 2, 2009).
ROSG Competitors
| Company | Last | Change |
| Exiqon A/S | kr10.00 DKK | 0.00 |
| Genomic Health Inc | $19.29 USD | +0.25 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | ROSG | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 19.8x |
|
| Price/Book | 2.4x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 8.8x |
|
|
ROSG |
||
ROSG transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
